| 公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
1 | 2024 | Association of TRAIL receptor with phosphatase SHP-1 enables repressing T cell receptor signaling and T cell activation through inactivating Lck | Chyuan, I-Tsu; Liao, Hsiu-Jung; Tan, Tse-Hua; Chuang, Huai-Chia; Chu, Yu-Chuan; Pan, Meng-Hsun; Wu, Chien-Sheng; CHING-LIANG CHU ; BOR-CHING SHEU ; PING-NING HSU | Journal of biomedical science | | | |
2 | 2022 | T Cell-Specific Deletion of TRAIL Receptor Reveals Its Critical Role for Regulating Pathologic T Cell Activation and Disease Induction in Experimental Autoimmune Encephalomyelitis | Chyuan, I-Tsu; CHING-LIANG CHU ; Hsu, Chia-Lang; Pan, Meng-Hsun; Liao, Hsiu-Jung; Wu, Chien-Sheng; PING-NING HSU | Journal of Immunology | 1 | | |
3 | 2021 | Targeting the Tumor Microenvironment for Improving Therapeutic Effectiveness in Cancer Immunotherapy: Focusing on Immune Checkpoint Inhibitors and Combination Therapies | Chyuan, I-Tsu; CHING-LIANG CHU ; PING-NING HSU | Cancers | 25 | 25 | |
4 | 2019 | Development of a PD-L1-Expressing Orthotopic Liver Cancer Model: Implications for Immunotherapy for Hepatocellular Carcinoma | DA-LIANG OU ; Lin, Yu-Yang; CHIA-LANG HSU ; Lin, Yin-Yao; Chen, Chia-Wei; Yu, Jhang-Sian; SHI-CHUEN MIAW ; PING-NING HSU ; ANN-LII CHENG ; CHIUN HSU | Liver cancer | 24 | 21 | |